Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Battista

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Dermatology and Therapy|February 27, 2025
Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa PatientFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Tropical Medicine and Infectious Disease|February 24, 2023
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|November 7, 2022
COVID-19 and cutaneous manifestations: A review of the published literatureFabrizio Martora, Alessia Villani, Gabriella Fabbrocini, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2025
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging AssociationFabrizio Martora, Teresa Battista, Antonella Giordano, et al.
Psoriasis (Auckland, N.Z.)|April 20, 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for PsoriasisLuca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Clinical, Cosmetic and Investigational Dermatology|March 24, 2025
Hidradenitis Suppurativa Cancer Risk: A Review of the LiteratureFabrizio Martora, Nello Tommasino, Teresa Battista, et al.
Clinical, Cosmetic and Investigational Dermatology|July 31, 2023
Nail Psoriasis: An Updated Review of Currently Available Systemic TreatmentsTeresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
Clinical and Experimental Dermatology|October 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational studySara Cacciapuoti, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology|April 15, 2024
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical TrialsLuca Potestio, Fabrizio Martora, Giuseppe Lauletta, et al.
Clinical, Cosmetic and Investigational Dermatology|March 13, 2024
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case ReportFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Dermatology and Therapy|February 27, 2025
Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa PatientFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Tropical Medicine and Infectious Disease|February 24, 2023
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|November 7, 2022
COVID-19 and cutaneous manifestations: A review of the published literatureFabrizio Martora, Alessia Villani, Gabriella Fabbrocini, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2025
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging AssociationFabrizio Martora, Teresa Battista, Antonella Giordano, et al.
Psoriasis (Auckland, N.Z.)|April 20, 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for PsoriasisLuca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Clinical, Cosmetic and Investigational Dermatology|March 24, 2025
Hidradenitis Suppurativa Cancer Risk: A Review of the LiteratureFabrizio Martora, Nello Tommasino, Teresa Battista, et al.
Clinical, Cosmetic and Investigational Dermatology|July 31, 2023
Nail Psoriasis: An Updated Review of Currently Available Systemic TreatmentsTeresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
Clinical and Experimental Dermatology|October 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational studySara Cacciapuoti, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology|April 15, 2024
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical TrialsLuca Potestio, Fabrizio Martora, Giuseppe Lauletta, et al.
Clinical, Cosmetic and Investigational Dermatology|March 13, 2024
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case ReportFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Pageof 4